Is there a subgroup of long-term evolution among patients with advanced lung cancer?: Hints from the analysis of survival curves from cancer registry data

Por Sanchez, Lizet, Lorenzo-Luaces, Patricia, Viada, Carmen, Galan, Yaima, Ballesteros, Javier, Crombet, Tania, Lage, Agustin
Publicado no BMC Cancer (2014)

Nimotuzumab in combination with radiotherapy in high grade glioma patients: A single institution experience

Por Solomon, Maria Teresa, Miranda, Nederlay, Jorrín, Eugenia, Chon, Ivonne, Marinello, Jorge Juan, Alert, José, Lorenzo-Luaces, Patricia, Crombet, Tania
Publicado em 2014

Immunosenescence and gender: a study in healthy Cubans

Por García Verdecia, Beatriz, Saavedra Hernández, Danay, Lorenzo-Luaces, Patricia, de Jesús Badía Alvarez, Teresita, Leonard Rupalé, Idrissa, Mazorra Herrera, Zaima, Crombet Ramos, Tania, Lage Dávila, Agustín
Publicado em 2013

Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Tr...

Por Caballero, Iraida, Aira, Lazaro E., Lavastida, Anabel, Popa, Xitlally, Rivero, Javier, González, Joaquín, Mesa, Mónica, González, Narjara, Coba, Kelly, Lorenzo-Luaces, Patricia, Wilkinson, Barbara, Santiesteban, Yuliannis, Santiesteban, Yanela, Troche, Mayelin, Suarez, Eduardo, Crombet, Tania, Sánchez, Belinda, Casacó, Angel, Macías, Amparo, Mazorra, Zaima
Publicado no Front Pharmacol (2017)